This is not the most recent version of the article. View current version (18 JAN 2012)

Intervention Protocol

Bezafibrate for primary biliary cirrhosis

  1. Jelena S Rudic1,5,*,
  2. Goran Poropat2,
  3. Miodrag N Krstic3,
  4. Goran Bjelakovic4,
  5. Christian Gluud5

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 11 MAY 2011

Assessed as up-to-date: 11 APR 2011

DOI: 10.1002/14651858.CD009145


How to Cite

Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Bezafibrate for primary biliary cirrhosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD009145. DOI: 10.1002/14651858.CD009145.

Author Information

  1. 1

    Clinic of Gastroenterology, Clinical Centre of Serbia, Department of Hepatology, Belgrade, Serbia

  2. 2

    Clinical Hospital Centre Rijeka, Department of Gastroenterology, Rijeka, Croatia

  3. 3

    Clinic of Gastroenterology, Clinical Centre of Serbia, Belgrade, Serbia

  4. 4

    Medical Faculty, University of Nis, Department of Internal Medicine - Gastroenterology and Hepatology, Nis, Serbia

  5. 5

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Jelena S Rudic, jelena_rudic@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 11 MAY 2011

SEARCH

This is not the most recent version of the article. View current version (18 JAN 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of bezafibrate in patients with primary biliary cirrhosis.